nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenic attack as a therapeutic strategy for cancer
|
Denekamp, Juliana |
|
1991 |
20 |
S |
p. 103-112 10 p. |
artikel |
2 |
Clinical trials with etanidazole (SR-2508) by the radiation therapy oncology group (RTOG)
|
Wasserman, Todd H. |
|
1991 |
20 |
S |
p. 129-135 7 p. |
artikel |
3 |
Consensus statement
|
|
|
1991 |
20 |
S |
p. 157- 1 p. |
artikel |
4 |
Consensus statement Session 3: How can tumour oxygenation be improved?
|
|
|
1991 |
20 |
S |
p. 81- 1 p. |
artikel |
5 |
Consensus statement Session 3: Potential of bioreductive drugs as hypoxic cytotoxins or: taking advantage of tumor hypoxia
|
|
|
1991 |
20 |
S |
p. 117- 1 p. |
artikel |
6 |
Consensus statement Session 1: the relevance and measurement of tumour hypoxia
|
|
|
1991 |
20 |
S |
p. 43- 1 p. |
artikel |
7 |
Could manipulation of the binding affinity of haemoglobin for oxygen be used clinically to sensitize tumours to radiation?
|
Hirst, David G. |
|
1991 |
20 |
S |
p. 53-57 5 p. |
artikel |
8 |
Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations
|
Chaplin, David J. |
|
1991 |
20 |
S |
p. 93-101 9 p. |
artikel |
9 |
Erratum
|
|
|
1991 |
20 |
S |
p. 159- 1 p. |
artikel |
10 |
Hyperbaric oxygen in the radiation treatment of head and neck cancers
|
Sealy, R. |
|
1991 |
20 |
S |
p. 75-79 5 p. |
artikel |
11 |
Hypoxia and local tumour control. Part 2
|
Dische, Stanley |
|
1991 |
20 |
S |
p. 9-11 3 p. |
artikel |
12 |
Hypoxia and local tumour control. Part 1
|
Gonzalez Gonzalez, D. |
|
1991 |
20 |
S |
p. 5-7 3 p. |
artikel |
13 |
Introduction
|
Van den Bogaert, W. |
|
1991 |
20 |
S |
p. 1- 1 p. |
artikel |
14 |
Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies
|
Chapman, J.D. |
|
1991 |
20 |
S |
p. 13-19 7 p. |
artikel |
15 |
Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85
|
Overgaard, J. |
|
1991 |
20 |
S |
p. 143-149 7 p. |
artikel |
16 |
Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs
|
Adams, G.E. |
|
1991 |
20 |
S |
p. 85-91 7 p. |
artikel |
17 |
Pathophysiological approaches to identifying tumor hypoxia in patients
|
Mueller-Klieser, W. |
|
1991 |
20 |
S |
p. 21-28 8 p. |
artikel |
18 |
Progress report of a phase II and a phase III trial with etanidazole (SR-2508): a multicentre european study
|
Chassagne, D. |
|
1991 |
20 |
S |
p. 121-127 7 p. |
artikel |
19 |
Radiosensitization with normobaric oxygen and carbogen
|
Rojas, A. |
|
1991 |
20 |
S |
p. 65-70 6 p. |
artikel |
20 |
Radiotherapy and anaemia — the clinical experience
|
Dische, Stanley |
|
1991 |
20 |
S |
p. 35-40 6 p. |
artikel |
21 |
SR 4233: A tumor specific radiosensitizer active in fractionated radiation regimes
|
artin Brown, J. |
|
1991 |
20 |
S |
p. 151-156 6 p. |
artikel |
22 |
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study
|
Bleehen, N.M. |
|
1991 |
20 |
S |
p. 137-142 6 p. |
artikel |
23 |
The potential of using hyperthermia to eliminate radioresistant hypoxic cells
|
Overgaard, J. |
|
1991 |
20 |
S |
p. 113-116 4 p. |
artikel |
24 |
The use of blood flow modifiers to improve the treatment response of solid tumors
|
Horsman, Michael R. |
|
1991 |
20 |
S |
p. 47-52 6 p. |
artikel |
25 |
The use of fluorocarbon emulsions in cancer radiotherapy
|
Guichard, Marcelle |
|
1991 |
20 |
S |
p. 59-64 6 p. |
artikel |
26 |
Tumor hypoxia and the positron data paradox
|
De Schryver, A. |
|
1991 |
20 |
S |
p. 41-42 2 p. |
artikel |
27 |
What have we learnt from hyperbaric oxygen?
|
Dische, Stanley |
|
1991 |
20 |
S |
p. 71-74 4 p. |
artikel |
28 |
What is the importance of anaemia in radiotherapy? The value of animal studies
|
Hirst, David G. |
|
1991 |
20 |
S |
p. 29-33 5 p. |
artikel |